Dr. Flory is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
530 East 74th Street
New York, NY 10021
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Endocrinology, Diabetes, and Metabolism, 2011 - 2013- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2009 - 2011
Perelman School of Medicine at the University of PennsylvaniaClass of 2009
Certifications & Licensure
FL State Medical License 2021 - Present
NY State Medical License 2011 - 2026
NJ State Medical License 2021 - 2025
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Clinical Trials
- Glucose Monitoring to Predict and Treat High Glucose Levels After Steroid Treatment Start of enrollment: 2019 Dec 20
- A Study of Glipizide to Treat High Blood Sugar in People With Pancreatic Cancer Start of enrollment: 2023 Dec 05
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Risk of Hypoglycemia Associated With Concomitant Use of Insulin Secretagogues and ACE Inhibitors in Adults With Type 2 Diabetes: A Systematic Review.Patricia Y Chu, Emma K Edmondson, James H Flory, Jing Huang, Sean Hennessy
Clinical Pharmacology and Therapeutics. 2025-04-01 - Using GPT-4o to interpret patient-reported outcomes without training.Thomas M Atkinson, Aleksandr Petrov, Kathleen A Lynch, Login S George, Jennifer R Cracchiolo
Journal of the National Cancer Institute. 2025-02-03 - 1 citationsLarge Language Model GPT-4 Compared to Endocrinologist Responses on Initial Choice of Glucose-Lowering Medication Under Conditions of Clinical Uncertainty.James H Flory, Jessica S Ancker, Scott Y H Kim, Gilad Kuperman, Aleksandr Petrov
Diabetes Care. 2025-02-01
Grant Support
- Managing metabolic disruption in pancreatic cancer to prevent weight loss and improve quality of lifeSLOAN-KETTERING INST CAN RESEARCH2023–2025
- Managing metabolic disruption in pancreatic cancer to prevent weight loss and improve quality of lifeSLOAN-KETTERING INST CAN RESEARCH2023–2025
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
